48North Cannabis Corp., - CEO, Charles Vennat
CEO, Charles Vennat
Source: 48North
  • 48North Cannabis (TSXV:NRTH) has appointed a new CEO
  • Charles Vennat, previously the company’s Chief Corporate Officer, has taken on the role 
  • Mr Vennat is replacing Alison Gordon, who served as 48North’s CEO for nearly three years
  • 48North (NRTH) is down 9.99 per cent, with shares currently trading at C$0.15

48North Cannabis (TSXV:NRTH) has appointed Charles Vennat as the company’s new Chief Executive Officer.

Mr Vennat is stepping into the role that Alison Gordon previously filled. Ms Gordon is leaving the company after serving as 48North’s CEO for almost three years.

Chair of 48North’s Board of Directors, Martin Cauchon, commented on Ms Gordon’s departure from the company.

“On behalf of the entire 48North team and our Board of Directors, I would like to thank Alison for her trailblazing leadership during her three years as 48North’s CEO.

“During her tenure, we introduced 48North’s initial suite of cannabis products to the recreational marketplace, opened one of the world’s largest licensed outdoor cannabis operations, raised significant capital, and built a strong brand.

We wish Alison all the best in her future endeavours,” he said.

Before his appointment to the role of CEO, Charles Vennat worked as 48North’s Chief Corporate Officer. He spoke with gratitude about his new position, before describing his ambitions for the company’s future.

“Over the past quarter, we have been diligently focused on operational upgrades, successfully conducting post-harvest activities from Good:Farm, building consumer loyalty, and preparing for the launch of our impressive suite of next-generation brands.

Looking ahead, I have every confidence that 2020 will be a momentous year for 48North. It is now time to leverage our industry-leading team to deliver reliable, high-quality, and consistent products for Canadian consumers,” he stated.

48North (NRTH) is down 9.99 per cent, with shares trading for C$0.15 at 12:11pm EST.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – July 26, 2024

Tilray Oral Solution THC10:CBD10 cannabis extract, aka Tilray Solução Oral THC10:CBD10, has been approved for medical use in Portugal.
medical branch logo

Tilray approved for third medical cannabis product in Portugal

Tilray Medical, a subsidiary of Tilray Brands (TSX:TLRY) has been approved for a new medical cannabis extract in Portugal.